Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950138-06-000698
Filing Date
2006-09-12
Accepted
2006-09-12 16:36:20
Documents
1
Period of Report
2006-09-07

Document Format Files

Seq Description Document Type Size
1 ROTH-STARK\2006\SEPT 12 FORM 3 - ISOLAGEN sept12_form3-isolagenex.html 3  
1 ROTH-STARK\2006\SEPT 12 FORM 3 - ISOLAGEN sept12_form3-isolagenex.xml 3 4138
  Complete submission text file 0000950138-06-000698.txt   6751
Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Issuer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 4142411810
ROTH MICHAEL (Reporting) CIK: 0001010207 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31564 | Film No.: 061086706

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 3600 SOUTH LAKE DR ST FRANCIS WI 53235 414 294 7000
STARK BRIAN JAY (Reporting) CIK: 0001010208 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31564 | Film No.: 061086705